Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11568763.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of terbinafine-induced agranulocytosis in a pediatric patient. This effect was noted 4 weeks after starting terbinafine and resolved within 1 week without the institution of therapy with granulocyte colony-stimulating factor, a course similar to reports in adults. With the incidence of severe side effects still unclear in children, this case argues for continued blood surveillance during courses of terbinafine and for the confirmation of infection before initiation of the drug.
Medical subject headings
- Agranulocytosis
- Antifungal Agents
- Naphthalenes